1. Home
  2. DOMH vs PRPO Comparison

DOMH vs PRPO Comparison

Compare DOMH & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DOMH
  • PRPO
  • Stock Information
  • Founded
  • DOMH 1967
  • PRPO N/A
  • Country
  • DOMH United States
  • PRPO United States
  • Employees
  • DOMH N/A
  • PRPO N/A
  • Industry
  • DOMH Biotechnology: Pharmaceutical Preparations
  • PRPO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • DOMH Health Care
  • PRPO Industrials
  • Exchange
  • DOMH Nasdaq
  • PRPO Nasdaq
  • Market Cap
  • DOMH 8.8M
  • PRPO 9.9M
  • IPO Year
  • DOMH N/A
  • PRPO N/A
  • Fundamental
  • Price
  • DOMH $11.94
  • PRPO $7.22
  • Analyst Decision
  • DOMH
  • PRPO
  • Analyst Count
  • DOMH 0
  • PRPO 0
  • Target Price
  • DOMH N/A
  • PRPO N/A
  • AVG Volume (30 Days)
  • DOMH 4.1M
  • PRPO 5.9K
  • Earning Date
  • DOMH 03-31-2025
  • PRPO 03-28-2025
  • Dividend Yield
  • DOMH N/A
  • PRPO N/A
  • EPS Growth
  • DOMH N/A
  • PRPO N/A
  • EPS
  • DOMH N/A
  • PRPO N/A
  • Revenue
  • DOMH $12,589,000.00
  • PRPO $17,411,000.00
  • Revenue This Year
  • DOMH N/A
  • PRPO $75.18
  • Revenue Next Year
  • DOMH N/A
  • PRPO N/A
  • P/E Ratio
  • DOMH N/A
  • PRPO N/A
  • Revenue Growth
  • DOMH 1117.50
  • PRPO 31.31
  • 52 Week Low
  • DOMH $0.83
  • PRPO $4.31
  • 52 Week High
  • DOMH $13.58
  • PRPO $7.55
  • Technical
  • Relative Strength Index (RSI)
  • DOMH 82.78
  • PRPO 62.56
  • Support Level
  • DOMH $6.31
  • PRPO $7.02
  • Resistance Level
  • DOMH $13.58
  • PRPO $7.55
  • Average True Range (ATR)
  • DOMH 1.72
  • PRPO 0.25
  • MACD
  • DOMH 1.00
  • PRPO 0.05
  • Stochastic Oscillator
  • DOMH 86.16
  • PRPO 73.78

About DOMH Dominari Holdings Inc.

Dominari Holdings Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company's oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia.

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

Share on Social Networks: